NIH Launches Study to Evaluate Three mRNA Vaccines for HIV
NIAID has launched a Phase I clinical trial evaluating three experimental HIV vaccines based on a mRNA platform — a technology used in several approved COVID-19 vaccines.
First Human Clinical Trial of Cancer Killing Virus Has Begun
A clinical trial of the Vaxina (the CF33-hNIS virus) designed to kill cancer cells has begun.
Flu Vaccines Poor Match to Influenza Strains This Season
According to CDC, this season’s influenza (flu) vaccines offered meager protection against mild cases of influenza.
FDA Approves New Gene Therapy Treatment for Rare Blood Disorder
FDA has given fast track approval for Bluebird Bio’s Zynteglo, a treatment designed to tackle the rare condition known as transfusion-dependent beta-thalassemia (TDBT).
New Program Launched to Identify Autoimmune Disease Therapies
A cross-disciplinary coalition of experts from academic centers across the United States is partnering with NIH, FDA, pharmaceutical companies and nonprofit organizations to identify new targets for therapies for autoimmune-meditated diseases.
Intranasal Flu Vaccine Developed with Nanoparticles
Researchers in a study funded by the National Institute of Allergy and Infectious Diseases and the National Institutes of Health have developed an influenza (flu) vaccine administered through the nose that has been constructed with nanoparticles and offers stronger protection.
Proposed Payment Systems and Fee Schedules in 2023
Proposed rules revising the Medicare Hospital Outpatient Prospective Payment System (OPPS) and the Medicare Ambulatory Surgical Center (ASC) services, along with new physician fee schedule (PFS) rule sets will significantly impact providers in 2023.
HHS Awards $1.5 Billion Grant to Combat Opioid Addiction
HHS (through SAMHSA) announced a State Opioid Response (SOR) grant funding of nearly $1.5 billion to help address the nation’s opioid addiction and overdose epidemic.
HHS Launches the Inaugural PandemicX 2022 Cohort
HHS has launched the PandemicX 2022 cohort, a program to accelerate private-public collaboration of 15 health tech startups.
NIH Establishes Antiviral Drug Discover Centers
NIH has awarded approximately $577 million to establish nine Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern.